- ►annals.org [PDF] F Andersohn, C Konzen, E Garbe - Annals of internal medicine, 2007 - Am Coll Physicians Background: Nonchemotherapy drug–induced agranulocytosis is a rare adverse
reaction that is characterized by a decrease in periph- eral neutrophil count to
less than 0.5 10 9 cells/L due to immu- nologic or cytotoxic mechanisms. Cited by 54 - Related articles - BL Direct - All 5 versions
E Andrès, F Maloisel - Current Opinion in Hematology, 2008 - journals.lww.com Introduction In 1922, Schultz [1] first proposed the term 'agranulocy- tosis'
for cases of severe pharyngeal infectious symptoms associated with the lack of
granulocytes in the peripheral blood. Agranulocytosis is marked by a ... Cited by 17 - Related articles - BL Direct - All 2 versions
MS BALKIN, M BUCHHOLTZ, J ORTIZ, AJ … - Thyroid, 1993 - liebertonline.com Page 1. THYROID Volume 3, Number 4, 1993 Mary Ann Liebert, Inc., Publishers Pp.
305-309 Propylthiouracil (PTU)-Induced Agranulocytosis Treated with ... Cited by 20 - Related articles - BL Direct - All 3 versions
E Andrès, J Zimmer, S Affenberger, L Federici, … - European Journal of Internal Medicine, 2006 - Elsevier In this paper, we review the literature on idiosyncratic drug-induced
agranulocytosis, a rare but life-threatening potential adverse event of most
drugs. Articles were identified through MEDLINE searches (1966–2005). ... Cited by 9 - Related articles - All 9 versions
TP Van Staa, F Boulton, C Cooper, A … - American journal of hematology, 2003 - igitur-archive.library.uu.nl The objectives of this study were to estimate the incidence of idiosyncratic
neutropenia and agranulocytosis in England and Wales and to evaluate their risk
factors and out- comes. The study was conducted using data from the General ... Cited by 24 - Related articles - View as HTML - BL Direct - All 5 versions
SHS Pearce - Clinical Endocrinology, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 43 - Related articles - BL Direct - All 5 versions
E Andrès, L Federici, T Weitten, T Vogel, M Alt - Expert Opin. Drug Saf., 2008 - informahealthcare.com Background: More than several hundred drugs, toxins, and herbs have been
reported to cause blood abnormalities, and drugs account for 20 – 40% of all
instances of cytopenias. Objective: In the present paper, we report and ... Cited by 4 - Related articles - All 6 versions
S FUKATA, K KUMA, M SUGAWARA - Thyroid, 1999 - liebertonline.com Page 1. THYROID Volume 9, Number 1, 1999 Mary Ann Liebert, Inc. Granulocyte
Colony-Stimulating Factor (G-CSF) Does Not Improve Recovery ... Cited by 67 - Related articles - BL Direct - All 3 versions
K Serraj, L Federici, F Maloisel, T Weitten, M … - john-libbey-eurotext.fr L'agranulocytose médicamenteuse (AM) est un désordre grave et imprévisible
qui impose de la part du clinicien une prise en charge adaptée [1]. Certaines
molécules comme les antithyroïdiens de synthèse (ATS) et la ticlopidine ... Related articles - All 2 versions
- ►oxfordjournals.org E Nitta, K Izutsu, T Sato, Y Ota, K Takeuchi, … - Annals of Oncology, 2007 - Eur Soc Med Oncology Results: With a median follow-up of 411 days, 23 patients developed LON out of
the 107 at a median of 106 days after the last chemotherapy. Cumulative
incidence of LON among the total patients was 24.9%. The median neutrophil ... Cited by 25 - Related articles - BL Direct - All 5 versions
